KPTI vs NTRS · rev $68.5M vs P/E 18, rev $2.69B
Karyopharm Therapeutics Inc (KPTI) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
KPTI currently screens at market cap $205.6M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the KPTI and NTRS stock pages for the full models.
Not investment advice.